MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
NCT: NCT07332182 · RECRUITING
광고
NCT IDNCT07332182
상태RECRUITING
완료2031-04-30
SponsorFin-Ceramica Faenza Spa (INDUSTRY)
First posted
Last updated
간략 요약
The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location. The evaluation will be performed through clinical, subjective and objective assessments.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.